论文信息 - Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial - 字舞流文

Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial

C. Kyriakou | J. Petrie | D. Paling | M. Bursnall | Katie Hullock | Gavin Brittain | Andy Peniket | Neil Scolding | Carolyn Young | Olga Ciccarelli | G. Giovannoni | Annalena Venneri | B. Sharrack | Diana Papaioannou | John A Snowden | Majid Kazmi | Thushan de Silva | Alasdair J Coles | Kate E M Duffy | Rachel Glover | Elisa Roldan | Colette Beecher | Cindy Cooper | Ian Gabriel | Richard Nicholas | Eli Silber | Stephen J Walters | Paolo A Muraro